The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Agricultural biotech firm Tropic Biosciences has secured regulatory approval for its non-browning banana in both Japan and Brazil, marking a significant milestone for the global fresh produce and foodservice sectors.

Backed by London-listed investor Agronomics, the innovation is positioned to reshape banana supply chains by reducing waste, extending usability and unlocking new commercial formats.

The newly approved variety maintains its colour and freshness long after peeling and slicing.

Approval in Japan signals strong regulatory confidence; Brazil’s approval is significant, as it is one of the largest banana producers and consumers. With Brazilian output accounting for around 10% of global production, the ability to cultivate the variety domestically opens the door to widespread adoption and supply chain integration.

Food waste remains a critical issue across the fruit category, especially with bananas, which are highly perishable once cut. Tropic’s innovation directly addresses this challenge by extending usability at multiple points along the value chain.

The company estimates that its broader banana portfolio, including an extended shelf-life variety, can reduce transportation waste by up to 50% while enabling new export routes through longer life.

The approvals in Japan and Brazil bring Tropic’s regulatory footprint to 11 countries, including major markets such as the US, Canada and the Philippines. Collectively, these regions represent more than 70% of global banana production and over 30% of consumption.

The milestone follows a strong year for Tropic, including a 105 million Series C funding round and the commercial launch of its banana varieties, the first new banana offerings in more than 75 years.

Looking ahead, Tropic plans to launch a Panama Disease-resistant banana by 2027, which could prove critical in safeguarding a global industry valued at approximately $25 billion.